In Vitro Evaluation of Sparfloxacin Activity and Spectrum Against 24,940 Pathogens Isolated in the United States and Canada, the Final Analysis

Sparfloxacin, a recently marketed oral fluoroquinolone, was tested against 24,940 recent clinical strains isolated from blood stream and respiratory tract cultures at 187 hospitals in the USA and Canada. Sparfloxacin activity was compared with 5 to 13 antimicrobial agents using either Etest (AB BIOD...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diagnostic microbiology and infectious disease 1998-05, Vol.31 (1), p.313-325
Hauptverfasser:	Jones, Ronald N, Ballow, Charles H, Schentag, Jerome J, Johnson, David M, Deinhart, June A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Canada Drug Evaluation, Preclinical Enterobacteriaceae - drug effects Fluoroquinolones Haemophilus - drug effects Humans Klebsiella - drug effects Medical sciences Microbial Sensitivity Tests Moraxella (Branhamella) catarrhalis - drug effects Penicillin Resistance Penicillins - pharmacology Pharmacology. Drug treatments Quinolones - pharmacology Staphylococcus aureus - drug effects United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!